Andreia S. Barros
Porto, 4200135, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeted nanoparticle delivery of irinotecan enhances tumor response to PD-L1 blockade in colorectal cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 29, 2025
Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 29, 2025
Oral delivery of tunable oxidation-responsive budesonide-loaded nanoparticles enhances inflammation modulation in intestinal colitis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 02, 2025
Orally Delivered Stimulus-Sensitive Nanomedicine to Harness Teduglutide Efficacy in Inflammatory Bowel Disease.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 28, 2024
Trends in 3D models of inflammatory bowel disease.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 23, 2023
All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 28, 2021
Mucus-producing 3D cell culture models.
Journal: Advanced drug delivery reviews
Published: June 09, 2021
Building three-dimensional lung models for studying pharmacokinetics of inhaled drugs.
Journal: Advanced drug delivery reviews
Published: January 08, 2020
Diffuse infantile hepatic haemangioma-how to manage an incidental but potentially lethal finding.
Journal: Oxford medical case reports
Published: December 17, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026